Diverse mechanisms activate the PI 3-kinase/mTOR pathway in melanomas: implications for the use of PI 3-kinase inhibitors to overcome resistance to inhibitors of BRAF and MEK
Khanh Bao Tran(University of Auckland), Peter R. Shepherd(University of Auckland)
Cited by 36
Related Papers
Phosphoinositide 3-kinase: the key switch mechanism in insulin signalling
|Biochemical Journal|1998|958
Atypical antipsychotic drugs induce derangements in glucose homeostasis by acutely increasing glucagon secretion and hepatic glucose output in the rat
|Diabetologia|2008|85
A role for PAK1 mediated phosphorylation of β-catenin Ser552 in the regulation of insulin secretion
|Biochemical Journal|2021|10